The measurement, correction, and clinical management of ametropia is the foundation of optometric practice. The optometrist is well aware of the concerns expressed by patients when correction is necessary: What causes it? Will it get worse? Does it run in families? Can it be treated? These are reasonable concerns given that ametropia is often a lifelong condition, carries the long-term economic burden of correction and in some instances can increase the risk of ocular pathology. Particular attention will be directed to myopia as this condition is now evident in around 25% of UK adolescents and is estimated to affect ~1Bn of the world’s ~6Bn population.
The module provides a contemporary account of relevant studies in epidemiology, physiology, biology and opto-electronic measurement that have provided new insight into the psychophysiological and neurobiological nature of myopia. Modern methods of genotyping have informed substantially the nature vs nurture debate concerning the onset and development of myopia. The module will demonstrate that there is scope to treat myopia by manipulation of the visual environment and will present the rational for current non-surgical options for treatment based on optical, pharmaceutical and behavioural studies.
The aim of the module is to enable participants to appreciate fully the nature of contemporary clinical research in myopia and understand its relevance to clinical practice in terms of the genesis, development and putative methods of treatment of myopia.
This module provides a solid academic foundation for Ophthalmic Doctorate students who may be considering undertaking their research projects in this field.